INS and diabetes mellitus: Current NICE guidelines advise against the use of CSII for people with T2D 67, and a consensus statement from ADA and European Association for the Study of Diabetes (EASD) in 2018 only briefly referred to a limited role for insulin pumps in a minority of people with T2D23.